Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Read more about Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Read more about Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Read more about The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
Immunotherapeutics in development for prostate cancer. Read more about Immunotherapeutics in development for prostate cancer.
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Read more about Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
Critical evaluation of current treatments in metastatic colorectal cancer. Read more about Critical evaluation of current treatments in metastatic colorectal cancer.
Bevacizumab in the treatment of breast cancer: rationale and current data. Read more about Bevacizumab in the treatment of breast cancer: rationale and current data.
Maximizing the potential of bevacizumab in cancer treatment. Read more about Maximizing the potential of bevacizumab in cancer treatment.
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Read more about Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.